期刊文献+

低分子肝素联合间歇充气加压预防人工关节置换术后下肢深静脉血栓形成 被引量:98

Low-molecular-weight heparin in combination with intermittent pneumatic compression on prophylaxis of deep venous thrombosis following arthroplasty
原文传递
导出
摘要 目的比较在手术前后不同时间使用低分子肝素(low-molecular-weightheparin,LMWH)联合间歇充气加压装置(intermittentpneumaticcompression,IPC)预防人工关节置换术后下肢深静脉血栓(deepvenousthrombosis,DVT)形成的效果和安全性。方法2003年7月至2005年6月,156例人工关节置换手术病例,随机分成4组。第1组38例,术前使用LMWH、麻醉开始时即使用IPC;第2组42例,术后使用LMWH、麻醉开始时即使用IPC;第3组36例,术前使用LMWH、术后使用IPC;第4组40例,术后使用LMWH与IPC。进行DVT症状评估、下肢深静脉的彩超检查,观察出血并发症与记录围手术期出血量。结果第1组,DVT2例(5.26%),出血量(1030.8±282.0)ml;第2组,DVT2例(4.76%),出血量(900.7±246.9)ml;第3组,DVT1例(2.78%),出血量(1040.3±288.5)ml,1例上消化道出血;第4组,DVT9例(22.5%),出血量(852.2±295.4)ml。在DVT发生率上,第1、2、3组明显低于第4组(P﹤0.05);在围手术期出血量上,第2、4组少于第1、3组(P﹤0.05)。结论术后使用LMWH联合麻醉开始时即使用IPC以预防人工关节置换术后DVT发生的效果好,安全性高。 Objective Examinating the efficacy and safety on prophylaxis of deep venous thrombosis(DVT) following arthroplasty using low-molecular-weight heparin (LMWH) in combination with intermittent pneumatic compression (IPC) starting with different time. Methods 156 patients undergoing primary arthroplasty from July 2003 to June 2005 were divided into four groups randomly. In the first group, 38 patients used LMWH preoperatively and IPC starting since anesthesia. In the second group, 42 patients did LMWH postoperatively and IPC starting since anesthesia. In the third group, 36 patients did preoperative LMWH and post-operative IPC. In the fourth group, 40 patients did post-operative LMWH and IPC. All patients were examined by colour duplex ultrasonography, valued the clinical symptom of DVT, recorded the volume of blood loss in perioperation and observed complication of hemorrhage. Results In the first group, two cases of DVT (5.26%) were found and the average perioperative volume of blood loss was (1030.8± 282.0) ml. In the second group, two cases of DVT (4.76%) were found and the average volume of blood loss was (900.7±246.9) ml. In the third group, one case (2.78%) of DVT was found and the average volume of blood loss was (1040.3±288.5) ml. In the fourth group, nine cases of DVT (22.5%) were found and the average volume of blood loss was (852.2±295.4) ml. Comparing the incidence of DVT between each group, group 1, 2, 3 were lower than group 4(P 〈 0.05). Comparing the volume of blood loss in perioperation, group 2 , 4 were less than group 1,3 (P 〈 0.05). Conclusion On the basis of this study, it is more effective and safer using LMWH staring with post-operative 10 h in combination with IPC starting with anesthesia on prophylaxis of DVT following arthroplasty.
出处 《中华骨科杂志》 CAS CSCD 北大核心 2006年第12期823-826,共4页 Chinese Journal of Orthopaedics
关键词 肝素 低分子量 静脉血栓形成 关节成形术 置换 临床试验 Heparin, low-molecular-weight Venous thrombosis Arthroplasty, replacement Clinical trials
  • 相关文献

参考文献13

  • 1Geerts WH,Pineo GF,Heit JA,et al.Prevention of venous thromboembolism:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest,2004,126 (3 Suppl):338-400.
  • 2Geerts WH,Heit JA,Clagett GP,et al.Prevention of venous thromboembolism.Chest,2001,119(1 Suppl):132-175.
  • 3Haas S.Prevention,diagnosis and therapy of thromboses in orthopedic and trauma surgery.Orthopade,1997,26:1062-1074.
  • 4邱贵兴,戴尅戎,杨庆铭,裴福兴,陈百成,曾炳芳,陈安民,王坤正,王继芳,余楠生,周乙雄,孙天胜,刘强,胡永成.预防骨科大手术后深静脉血栓形成的专家建议——深静脉血栓形成预防座谈会纪要[J].中华骨科杂志,2005,25(10):636-640. 被引量:477
  • 5Raskob GE,Hirsh J.Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery.Chest,2003,124(6 Suppl):379-385.
  • 6Silbersack Y,Taute BM,Hein W,et al.Prevention of deep-vein thrombosis after total hip and knee replacement:low-molecularweight heparin in combination with intermittent pneumatic compression.J Bone Joint Surg(Br),2004,86:809-812.
  • 7Ryan MG,Westrich GH,Potter HG,et al.Effect of mechanical compression on the prevalence of proximal deep venous thrombosis as assessed by magnetic resonance venography.J Bone Joint Surg (Am),2002,84:1998-2004.
  • 8Flam E,Berry S,Coyle A,et al.Bloodflow augmentation of intermittent pneumatic compression systems used for prevention of deep vein thrombosis prior to surgery.Am J Surg,1996,171:312-315.
  • 9Kohro S,Yamakage M,Sato K,et al.Intermittent pneumatic foot compression can activate blood fibrinolysis without changes in blood coagulability and platelet activation.Acta Anaesthesiol Scand,2005,49:660-664.
  • 10Wang WZ,Fang XH,Stepheson LL,et al.NOS upregulation attenuates vascular endothelial dysfunction in the late phase of ischemic preconditioning in skeletal muscle.J Orthop Res,2004,22:578-585.

二级参考文献30

  • 1Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, 126(3 Suppl): 338-400.
  • 2Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation, 2003, 107(23 Suppl 1): 9-16.
  • 3Liew NC, Moissinac K, Gul Y. Postoperative venous thromboembolism in Asia: a critical appraisal of its incidence. Asian J Surg,2003, 26: 154-158.
  • 4Geerts WH, Heir JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest, 2001, 119(1 Suppl): 132-175.
  • 5Turpie AG, Bauer KA, Eriksson BI, et al. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med, 2002, 162: 1833-1840.
  • 6Fitzgerald RH Jr, Spiro TE, Trowbridge AA, et al. Prevention of venous thromboembolic disease following primary total knee arthroplasty. J Bone Joint Surg(Am), 2001, 83: 900-906.
  • 7Kearon C. Duration of venous thromboembolism prophylaxis after surgery. Chest, 2003, 124(6 Suppl): 386-392.
  • 8O'Donnell M, Linkins LA, Kearon C, et al. Reduction of out-of-hospital symptomatic venous thromboembolism by extended thromboprophylaxis with low-molecular-weight heparin following elective hip arthroplasty: a systematic review. Arch Intern Med, 2003, 163:1362-1366.
  • 9Samama CM, Vray M, Barre J, et al. Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of lowmolecular-weight heparin with oral anticoagulant. Arch Intern Med,2002, 162: 2191-2196.
  • 10AIDA: 45th American Society of Hematology Annual Meeting. San Diego, 2003.

共引文献476

同被引文献837

引证文献98

二级引证文献1908

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部